Introduction
Glucocorticoids (GCs) are known to be potent immunosuppressive, antiallergic, and anti-inflammatory drugs. They exert their effects on target cells by binding to an intracellular glucocorticoid receptor (GR). The ability of GCs to induce apoptosis and cell cycle arrest in lymphoid cells has resulted in their widespread use as chemotherapeutic agents for various leukemias, lymphomas, and multiple myelomas, although the precise mechanism of their actions is yet to be elucidated. 1, 2 Glucocorticoid receptor (GR) is a member of the nuclear hormone receptor superfamily localized in the cytoplasm. Inactive GR is bound to a large protein complex that includes heat shock protein 90 (Hsp90). When GC binds to GR, Hsp90 dissociates and the GC/GR complex translocates to the nucleus where it binds to specific palindromic sequences, termed glucocorticoid response elements (GREs), resulting in the transcriptional upregulation of various genes. 3 We previously investigated transcriptional changes during GCinduced apoptosis in GC-sensitive human pre-B leukemia 697 cells harboring the t(1;19) chromosomal translocation 4 using oligonucleotide microarrays. 5 Among 93 genes induced by a synthetic GC, dexamethasone (DEX), were Granzyme A (GZMA), and two other genes encoding calcineurin inhibitors, FK506 binding protein 51 (FKBP5) and Down syndrome critical region gene 1 (DSCR1). Granzymes are serine proteases and are packaged in cytotoxic granules of CTL and NK cells, together with the pore-forming protein perforin. The concerted action of these molecules induces apoptosis of target cells, such as infected cells or transformed tumor cells. 6, 7 DSCR1, a gene located on chromosome 21, is highly expressed in fetal brain and is suggested to have a role in brain development. The product of DSCR1 interacts with the catalytic A subunit of calcineurin and inhibits its phosphatase activity, and thus is also called modulatory calcineurin-interacting protein 1 (MCIP1).
8 FKBP5 encodes FK506 binding protein of 51 kDa, which is known as an immunophillin, and also regulates the inhibition of calcineurin. 9, 10 These three genes are suggested to mediate GC-induced apoptosis in lymphoid cells by the following findings. First, the granzyme inhibitor 3,4-dichloroisocoumarin has been reported to inhibit DEX-induced apoptosis of 697 cells. 11 Second, the activation of calcineurin protects T cells from GC-induced apoptosis. 12, 13 Moreover, using a variety of pre-B leukemic cells, the expression of the latter two genes evoked by GC and the induction of apoptosis were found to be closely correlated. 5 However, the induction of these genes does not necessarily mean that they are direct transcriptional targets, because they may be regulated via a secondary effect induced by the primary targets of GC. In addition, GR regulates transcription by binding to and inhibiting or enhancing the function of other transcription factors such as AP-1, NF-kB, and the STAT family of transcription factors, which can change the transcriptional profile.
14,15 Therefore, we investigated the genomic organization of these genes and whether they are direct target genes of GR.
Materials and methods

Cells and reagents
Pre-B human leukemia 697 cells were routinely grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 50 U/ml of penicillin, and 0.1 mg/ml of streptomycin. HeLa and COS-7 cells were maintained in DMEM with the same supplements. DEX and cycloheximide (CHX) were purchased from Sigma.
Plasmid construction
To generate pGRE-Luc, the oligonucleotides 5 0 -TCGATCAGAA CACTGTGTTCTGA-3 0 and 5 0 -TCGATCAGAACACAGTGTTCT GA-3 0 were annealed and subcloned into the XhoI site of pGV-P2 (Wako Chemicals, Osaka, Japan). Genomic sequences corresponding to human GZMA, FKBP5, and DSCR1 were amplified by PCR with appropriate primers using the Expand High Fidelity PCR system (Roche Diagnostics) and subcloned into a luciferase vector, pGV-B2 or pGV-P2 (Wako Chemicals). Reporter constructs with mutated sequences were generated by the PCR-based method described previously. 16 Detailed information on the primers used for the PCR is available at Leukemia's website. All the constructs were verified by DNA sequencing.
Analysis of gene expression by RT-PCR
To analyze the isoform-specific regulation of DSCR1, 500 ng of total RNA extracted from 697 cells was reverse-transcribed and cDNA was amplified by PCR using a forward primer specific to DSCR1 exon 1 or 4, and a reverse primer for exon 5. Logarithmically amplifying PCR product was subjected to agarose gel electrophoresis. For real-time RT-PCR, one-step RT-PCR was performed using a 7700 ABI PRISM Sequence Detector System (Perkin Elmer-Applied Biosystems). Fluorogenic probes carrying 5 0 6-carboxy-fluorescein as a reporter dye and 3 0 6-carboxy-tetramethyl-rhodamine as a quencher dye were used to detect the PCR product. In every experiment, the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was amplified using a series of dilutions of a known amount of the standard RNA supplied by Perkin Elmer to prepare a standard curve. Data analysis was performed as described 17 with slight modifications. Detailed information on the primers used for the PCR is available at Leukemia's website.
Western blot analysis
Western blot analysis was performed as described previously 5 using goat anti-FKBP51 polyclonal antibody (F-13, Santa Cruz) followed by horseradish peroxidase-conjugated donkey anti-goat immunoglobulins (Santa Cruz). The proteins were visualized using an enhanced chemiluminescence method (Amersham).
Transfection and luciferase assay
HeLa cells growing in six-well plates were transfected with 750 ng of the reporter gene plasmid along with 500 ng of pCMVbGal and 750 ng of an expression plasmid for rat GR, p6RGR 18 (a gift from Keith Yamamoto), using Effectene reagent (Qiagen). The medium was replaced with DMEM without phenol red (Invitrogen) with 10% charcoal-treated fetal calf serum just before the lipofection. The cells were harvested at 16 h after transfection and used for a luciferase assay. Luciferase activities were measured as described previously and normalized for transfection efficiency based on b-galactosidase activities. 19 Electrophoretic mobility shift assay COS-7 cells were transfected with p6RGR and 10 À6 M of DEX was added. Nuclear extract was prepared 48 h after transfection by three cycles of freezing and thawing in cell resuspension buffer (40 mM HEPES-KOH, pH 7.9, 0.4 M KCl, 1 mM dithiothreitol, 10% glycerol, 0.1 mM phenylmethylsulfonyl fluoride, and 0.1% aprotinin) and incubated with an end-labeled doublestranded oligonucleotide probe:
The reaction was performed in 15 ml of binding buffer (4% glycerol, 1 mM MgCl 2 , 0.5 mM EDTA, 50 mM NaCl, 10 mM Tris-HCl (pH 7.5), and 0.05 mg/ml poly(dI-dC)) for 20 min at room temperature. The supershift analysis was performed by including anti-GR polyclonal antibody (Affinity Bioreagents) in binding reactions. Samples were fractioned on a nondenaturing 6% polyacrylamide gel and visualized by autoradiography.
Results
Three candidate target genes are upregulated by GC in the absence of de novo protein synthesis
We and others have identified GZMA, FKBP5, and DSCR1 as GC-responsive genes using microarray technology. 5, [20] [21] [22] [23] However, it is likely that some of the GC-induced genes identified are regulated because of secondary effects induced by the primary targets of GC. To rule out this possibility, we analyzed the effect of GC in the presence and absence of an inhibitor of protein synthesis, CHX. Evidently, protein synthesis was indeed shut down by CHX as the level of FKBP5 protein declined in cells growing in the presence of CHX even after DEX treatment, in contrast to the experiment without CHX (Figure 1a ). Hence, direct target genes of GC will be transcriptionally activated, but because of the inhibition of protein synthesis, the GC-induced proteins will not be synthesized and will not induce secondary Three genes are directly upregulated by DEX. (a) Cell lysates were obtained from 697 cells treated with 10 À6 M of DEX for the periods indicated and subjected to Western blotting to detect FKBP5. In some experiments (indicated by þ CHX), 10 mg/ml of CHX was added at 16 h prior to DEX treatment. (b) Transactivation of the three genes by DEX is CHX-insensitive. 697 cells growing in the presence (open columns) or absence (closed columns) of CHX for 16 h were treated with DEX for the periods indicated and then total RNA was extracted. cDNA encoding the three genes was amplified by RT-PCR and analyzed with a 7700 ABI PRISM Sequence Detector System. The expression of the genes normalized to that of GAPDH is shown. The analysis was performed in triplicate.
Identification of target genes of glucocorticoid receptor M U et al or indirect targets in this experimental system. As shown in Figure 1b , these three genes were induced significantly irrespective of the presence of CHX as assessed by real-time RT-PCR, suggesting that their expression was induced directly by GC without the need for protein synthesis.
The exon 1 variant of DSCR1 is responsive to GC The human DSCR1 gene was reported to express four variant mRNAs with each of four alternative exons (exons 1-4) incorporated selectively at the 5 0 terminus of the expressed transcript. 8 The majority of these transcripts were identified to represent isoforms that include exon 1 or 4 ( Figure 2a ) and the other two were not detectable in human fetal and adult tissues by Northern analysis. 8 Exon 1 and 4 isoforms use distinct promoters and their transcription is differentially regulated. For example, expression of the exon 4 isoform, but not the exon 1 isoform, is selectively increased by calcineurin activity, creating a negative feedback circuit. 24 To address the issue of which variant is responsible for the upregulation of DSCR1 by GC, we constructed RT-PCR primers that specifically recognize these isoforms ( Figure 2a ). As shown in Figure 2b , transcription of the exon 1 isoform (Exon1-5) is upregulated by DEX showing a similar time course as total DSCR1 expression (Exon7-7). However, the exon 4 isoform (Exon4-5) was barely detectable in 697 cells and its expression level was not increased after the treatment with DEX. The exon 4 isoform was detected in the heart and kidney in which this variant was reported to be significantly expressed, 8 demonstrating that these primers were capable of efficiently recognizing the exon 4 isoform (Figure 2c) . Collectively, GCs were demonstrated to upregulate the exon 1 isoform of DSCR1. Since DSCR1 spliced from exons 1 and 4 would generate DSCR1 proteins with distinct N-terminus, it would be interesting to see if there is a difference in calcineurin inhibition between these two protein variants.
Intronic regions of GZMA and FKBP5 are required for a transcriptional response to GC Having shown that the expression of the three genes was induced directly by GC, we amplified the promoter and intron fragments from human genomic DNA by PCR and subcloned them into a luciferase vector in order to further substantiate the role of the transcriptional activation of these genes. Despite extensive analysis of the reporter gene, no sequence responsive to GC was identified in the region around exon 1 for DSCR1 (at least not up to B2.2 kb and down to B2.0 kb from exon 1), although a couple of candidate GREs were found in this region (data not shown). These results suggest that the functional GRE is located at a position distant from exon 1 or the transactivation of DSCR1 is mediated by a nonclassical mechanism.
The GZMA promoter was also unresponsive to GC at least up to B2.3 kb from exon 1 (Figure 3a , pGV-GzmPro). However, when an B2.7 kb fragment of intron 1 was subcloned into a reporter vector, it was significantly upregulated by DEX (pGVGzmInt). The degree of induction was more than two-fold that with pGV-GRE in which the consensus 1 Â GRE (5 0 -AGAA CACTGTGTT-3 0 ) was subcloned. To narrow down the region reactive to GC, the 2.7 kb segment was divided into three and various deletion mutants were tested for the response to DEX. As shown in Figure 3b , the response to DEX was completely eliminated when the middle segment of B1 kb was deleted from the construct (pGV-GzmIntA and pGV-GzmIntC) indicating the presence of a GC-responsive element in this fragment. It was also suggested that the downstream sequence in intron 1 has an inhibitory effect on GC-induced transactivation since the constructs lacking this segment showed significantly higher induction (pGV-GzmIntAB and pGV-GzmIntB). In fact, inspection of the DNA sequence in this middle segment revealed the presence of four candidate GREs that partially match the previously reported consensus sequence (numbered GRE1 to GRE4 as shown in Figure 3c ). We therefore introduced a series of nucleotide substitutions at these sites to map the actual GREs. When either GRE3 or GRE4 was mutated, DEX-mediated transactivation was markedly compromised down to less than 10-fold (pGV-GzmIntB3, pGV-GzmIntB4). In addition, their combined mutations virtually eliminated DEX-mediated transactivation (pGV-GzmIntB234, pGV-GzmIntB1234). In contrast, reporter constructs with a mutation of either GRE1 or GRE2 still showed more than 20-fold activation by DEX (pGV-GzmIntB1, pGV-GzmIntB2). These results imply that GRE3 and GRE4 are functional GREs, although GRE1 and GRE2 may have an auxiliary role.
The FKBP5 gene was similarly examined for the presence of a functional GRE. Again, the promoter sequence of B2 kb did not respond to the treatment with DEX (Figure 4a, pGV-FKBPPro) . RT-PCR was performed similarly except that RNAs from human tissues were used as templates.
Identification of target genes of glucocorticoid receptor M U et al
Since introns 1 and 2 are B46 and B5.5 kb long, respectively, we inspected the vicinity of exons 1 and 2 for the presence of possible GREs. Four candidate GREs found in this region were subcloned into a luciferase vector and subjected to reporter gene analyses (Figure 4a ). The luciferase constructs containing two candidate GREs in intron 2 (pGV-FKBPIntC) significantly responded to DEX to the same degree as pGV-GRE, whereas the constructs containing the other two candidate GREs in intron 1 were unresponsive to DEX (pGV-FKBPIntA and pGV-FKBPIntB).
When the downstream GRE of pGV-FKBPIntC, but not the upstream one, was mutated, the response was virtually eliminated, suggesting that the downstream GRE is functional (Figure 4b, pGV-FKBPIntCmt2 ).
GR can bind in vitro to an oligonucleotide probe representing the GZMA and FKBP5 gene region
To determine whether the GR protein can bind to the sequences corresponding to the GREs in GZMA and FKBP5 that proved to be functional in reporter gene assays, electrophoretic mobility shift assays were performed. As shown in Figure 5a , when nuclear extracts were obtained from COS-7 cells transiently transfected with expression plasmid for GR and incubated with a radiolabeled DNA probe containing a GRE sequence in the intronic region, a complex with a shift in gel mobility was detected (lanes 1, 4, and 7). When anti-GR antibody was included in binding reactions, the bands detected in the lanes The middle part of intron 1 is GC-responsive. To narrow down the region reactive to DEX, intron 1 was divided into three and subcloned into the reporter vector as depicted in the upper panel. Luciferase assays were performed and expressed as described in (a). (c) Identification of GRE in intron 1. Candidate GRE sequences were mutated as indicated by a PCR-based method. Lowercase letters indicate mutated nucleotides. Thick vertical bars represent the location of candidate GREs. Mutated GREs are marked by asterisks. Luciferase assays were performed and the results were expressed as described in (a).
Identification of target genes of glucocorticoid receptor M U et al mentioned above were replaced by supershifted bands (lanes 2, 5, and 8), demonstrating the specificity of the complex formation. These results indicate that GR binds to the GRE sequences in the GZMA and FKBP5 genes in vitro, which were identified by reporter gene assays.
Discussion
Although a number of reports have been published on the genome-wide screening of GC-induced genes, 5, [20] [21] [22] [23] 25 to our knowledge, no reports have dealt with the molecular mechanism of how screened genes are transactivated by GC. Among the genes screened in our previous study, we focused on GZMA, DSCR1, and FKBP5, which have reportedly been relevant to GC-induced apoptosis, and found that all three are direct targets of GC. In the GZMA and FKBP5 genes, GC-responsive intronic sequences to which GR can bind in vitro have been determined.
None of the promoter sequence we analyzed responded to GC. However, this is not unexpected because a number of transcription factors, for example p53, transactivate target genes by binding to intronic sequences. [26] [27] [28] Recently, it was reported that B400 bp of promoter sequence of human FKBP5 exhibited upregulation by progestin in human breast cancer cells. 29 In contrast, our reporter construct, which contained this region, was unresponsive to GC, although the receptors for GC and progestin are known to recognize a sequence that is similar, if not the same. 30 Given their findings that no classical progestinresponsive element was identified in this region and the activity of luciferase was stimulated only 2.5-fold by a progesterone analog, much weaker than 410-fold effect observed in our study, it is speculated that progestin mainly regulates the Regulation of the FKBP5 intron by GC. (a) The genomic organization of the human FKBP5 gene and reporter gene constructs used for luciferase assays are schematically depicted at the top. Open and filled boxes indicate a noncoding and a coding exon, respectively. Exons 1 and 2 are separated by a sequence B46 kb long. Numbers in parentheses denote nucleotide positions relative to the translational initiation site in exon 2 based on the genomic sequence, AL033519 and AL590400. Thick vertical bars represent the location of candidate GREs. Luciferase assays were performed and the results were expressed as described in Figure 3 . (b) Identification of GRE in intron 2. Candidate GRE sequences were mutated as indicated by a PCRbased method. Lowercase letters indicate mutated nucleotides. Mutated GREs are marked by asterisks. Luciferase assays were performed and the results were expressed as described in Figure 3 .
Figure 5
Electrophoretic mobility shift assays and alignment of GC-reactive sequences. (a) GR can bind in vitro to an oligonucleotide probe representing the GZMA and FKBP5 gene region. Nuclear extracts were obtained from COS-7 cells transiently transfected with expression plasmid for GR and incubated with Identification of target genes of glucocorticoid receptor M U et al transcription of FKBP5 through the intronic sequence we identified rather than a promoter sequence. The DNA sequences that were responsive to DEX in our study were aligned in Figure 5b . The recognition sequence of GR is defined as a 15-bp motif with partial dyad symmetry such as 5 0 -GGTACAnnnTGTTCT-3 0 . 31 However, a mutagenesis study indicated that some sequences that do not perfectly fit into the consensus sequence are still GC-responsive. 30 Based on our results, three repeats of 5 0 -WGWWCW-3 0 separated by 1-4 bp are responsive to GC in which the second motif needs to have a perfect match. However, the presence of this sequence alone does not result in a functional GRE. Indeed, the sequence in GZMA that fulfills this consensus sequence, for example GRE2 in Figure 3c , was not functional, because disruption of this candidate GRE had little effect on the response to GC. Therefore, the induction potential of a given site is speculated to be a complex function in the context of the higher gene structure.
The molecular mechanism of GC-induced apoptosis is not fully understood. In the first place, it is necessary for GR to function as a transactivator in order to induce apoptosis, because mutant GR incapable of binding DNA fails to induce thymocyte apoptosis 32 and inhibition of de novo protein synthesis by CHX virtually eliminated DEX-induced apoptosis in 697 cells (data not shown). In addition to the genes investigated in this study, the Bim gene (BCL2L11) has recently been reported to be induced by GC in murine lymphoma cell lines. 25 Bim protein is a BH3-only member of the Bcl-2 family that is capable of directly activating the apoptotic cascade. 33 It is therefore an attractive candidate for a GC target gene that mediates apoptosis. However, at least in our microarray analysis, Bim expression was not induced at any time points examined after DEX treatment, although its expression at low levels was observed (data not shown). Thus, we conclude that Bim is unlikely a target of GC that generally mediates GCinduced apoptosis. Nevertheless, the levels of Bim expression may determine the sensitivity of leukemic cells to GC, since GCinduced apoptosis is partially impaired in hematopoietic cells from Bim À/À mice. 34 Is one of the genes investigated here solely responsible for GC-induced cell death? We established a lentivirus-mediated small interference RNA delivery system to selectively knock down FKBP5 or DSCR1. The knocking-down of a single gene, however, was not sufficient to significantly inhibit GC-induced apoptosis, suggesting that multiple GR-induced genes activate a network of pathways that contribute to apoptosis (data not shown). This is reminiscent of p53-induced apoptosis. More than 16 target genes of p53 have been proposed to mediate apoptosis, but it is still unclear whether any single target gene is critical. Several lines of evidence suggest that the signaling pathway of p53-induced apoptosis is cell type-dependent and two or more genes cooperate to induce cell death in certain situations. 35, 36 In this regard, it should be noted that the granzyme K gene, GZMK, is also significantly upregulated by GC (data not shown). GZMK encodes a serine protease that has features common to granzyme A, and the two genes are only B70 kb apart on human chromosome 5. Thus, GZMK may be another target of GC that mediates apoptosis. Generating mice doubly deficient in GC target genes would help to clarify the signal transduction of GC-induced apoptosis. Expression profiling of the genes described in this study will contribute to predictions of responsiveness or resistance to GC therapy. Further study of GC target genes will provide the rationale for the optimal use of GC to improve treatment outcome in leukemia.
